Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone
- Status
- WITHDRAWN
- Phase
- PHASE1
Micro RNAs to Predict Response to Androgen Deprivation Therapy
- Status
- COMPLETED
- Phase
- N/A
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing
- Status
- COMPLETED
- Phase
- N/A
Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
- Status
- COMPLETED
- Phase
- PHASE3
Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone
- Status
- COMPLETED
- Phase
- PHASE3
Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
- Status
- COMPLETED
- Phase
- PHASE2
EXTEND Exercise Trial
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
- Status
- COMPLETED
- Phase
- N/A